メタボロミクスサービスの世界市場レポート 2024年

メタボロミクスサービス市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR14.6％で45億7,000万米ドルに成長します。予測期間中に予想される成長は、がんの有病率の上昇、個別化医療への需要の高まり、ライフサイエンスとバイオテクノロジーにおける用途の拡大、疾病負担の増加、医療インフラの進歩など、いくつかの要因に関連しています。この期間に予想される主要動向には、技術革新、機械学習の利用、バイオインフォマティクスツールの進歩、人工知能の統合、新しい診断ツールの開発などがあります。

個別化医療に対する需要の高まりは、メタボロミクスサービス市場の拡大を促進すると予測されます。個別化医療は、遺伝子プロファイル、環境要因、ライフスタイルの選択に基づいて、医療に関する意思決定や治療を個々の患者に合わせるものです。このような需要の高まりは、より正確でカスタマイズ型治療を可能にするゲノム技術の進歩や、転帰を改善するための個別化された患者ケアへの注目の高まりに後押しされています。メタボロミクスサービスは、詳細な代謝プロファイルを提供することで個別化医療をサポートし、各患者固有の生化学的状態に応じて治療をカスタマイズするのに役立ち、その結果、より効果的で的を絞った治療が可能になります。例えば、米国を拠点とする専門組織であるPersonalized Medicine Coalitionは、2022年に12の新しい個別化治療が承認され、これは新たに承認された全治療の約34%に相当し、以前に比べて顕著な増加を示していると報告しています。その結果、個別化医療需要の急増がメタボロミクスサービス市場の成長を促進しています。

メタボロミクスサービス市場の主要企業は、病気の発見を改善し個別化医療をサポートする診断ツールを開発しています。これらの診断ツールは病状の特定と評価に使用され、医療専門家が正確な診断を下し、治療方針を決定するのに役立っています。例えば、2023年10月、米国のバイオテクノロジー企業であるSapient Bioanalytics LLCは、バイオマーカー探索と迅速な洞察のための標的代謝物と脂質パネルを発表しました。これらのパネルは、特定の代謝物や脂質を同定・定量することに重点を置いており、バイオマーカーの検出精度を高めています。迅速な結果を得るために設計されたこれらのパネルには、複雑な代謝プロファイルを解釈するための先進的データ分析ツールが含まれており、研究と臨床の両方の環境においてタイムリーな意思決定を行うために重要な、実用的な洞察を記載しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のメタボロミクスサービス市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のメタボロミクスサービス市場の実績：規模と成長、2018～2023年
• 世界のメタボロミクスサービス市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のメタボロミクスサービス市場：タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
• 非対象メタボロミクスサービス
• 対象メタボロミクスサービス
• 世界のメタボロミクスサービス市場：製品とサービス別、実績と予測、2018～2023年、2023～2028年、2033年
• メタボロミクスバイオインフォマティクスサービス
• クロマトグラフィー
• 質量分析
• その他の製品とサービス
• 世界のメタボロミクスサービス市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
• 農業と食品
• バイオメディカルと製薬
• 学術ラボ
• 診断ラボ
• その他

第7章 地域別・国別分析

• 世界のメタボロミクスサービス市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のメタボロミクスサービス市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• メタボロミクスサービス市場：競合情勢
• メタボロミクスサービス市場：企業プロファイル
  • BASF SE
  • Waters Corporation
  • Bruker Corporation
  • RTI International
  • SCIEX

第31章 その他の大手企業と革新的企業

• BGI Group
• Fred Hutchinson Cancer Research Center
• OWL Inc.
• LECO Corporation
• Metabolon Inc.
• MetaSysX Inc.
• Nightingale Health
• Biocrates Life Sciences AG
• Human Metabolome Technologies America Inc.
• CosmosID
• Centre for Cellular and Molecular Platforms
• Creative Proteomics
• Cogentech
• Stemina Biomarker Discovery Inc.
• Thermal Management Innovations Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

Metabolomics services involve analytical and technological methods used to examine the metabolites present in a biological system. Metabolites are small molecules resulting from cellular processes, and analyzing them offers insights into the physiological condition of an organism. This approach is valuable for exploring disease mechanisms, identifying biomarkers, and enhancing drug development and personalized medicine.

There are two primary types of metabolomics services such as untargeted and targeted metabolomics. Untargeted metabolomics encompasses a broad analysis of all detectable metabolites in a sample without specific targets in mind. Various products and services available in this field include metabolomics bioinformatics, chromatography, mass spectrometry, and others. These services cater to diverse end-users, such as those in agriculture, food, biomedical and pharmaceutical industries, academic and research institutions, diagnostic labs, and more.

The metabolomics services market research report is one of a series of new reports from The Business Research Company that provides metabolomics services market statistics, including metabolomics services industry global market size, regional shares, competitors with a metabolomics services market share, detailed metabolomics services market segments, market trends and opportunities, and any further data you may need to thrive in the metabolomics services industry. This metabolomics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metabolomics services market size has grown rapidly in recent years. It will grow from $2.32 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 14.4%. The growth observed during the historic period can be attributed to several factors, a heightened emphasis on biomarker discovery, a growing demand for sophisticated diagnostic tools, increased use in agricultural research, a rise in the number of clinical trials, and greater awareness of the applications of metabolomics.

The metabolomics services market size is expected to see rapid growth in the next few years. It will grow to $4.57 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The anticipated growth during the forecast period can be linked to several factors, the rising prevalence of cancers, growing demand for personalized medicine, expanding applications in life sciences and biotechnology, increasing disease burden, and advancements in healthcare infrastructure. Key trends expected during this period include technological innovations, the use of machine learning, advancements in bioinformatics tools, integration of artificial intelligence, and the development of new diagnostic tools.

The growing demand for personalized medicine is anticipated to drive the expansion of the metabolomics services market. Personalized medicine tailors healthcare decisions and treatments to individual patients based on their genetic profiles, environmental factors, and lifestyle choices. This rising demand is fueled by advancements in genomic technologies, which enable more precise and customized treatments, as well as an increased focus on individualized patient care for improved outcomes. Metabolomics services support personalized medicine by offering detailed metabolic profiles that help in customizing treatments according to each patient's unique biochemical state, resulting in more effective and targeted therapies. For example, the Personalized Medicine Coalition, a US-based professional organization, reported that in 2022, 12 new personalized medications were approved, representing about 34% of all newly approved treatments, marking a notable increase from previous years. Consequently, the surge in personalized medicine demand is propelling the growth of the metabolomics services market.

Leading companies in the metabolomics services market are advancing diagnostic tools to improve disease detection and support personalized medicine. These diagnostic tools are used to identify and evaluate medical conditions, helping healthcare professionals make accurate diagnoses and inform treatment decisions. For instance, in October 2023, Sapient Bioanalytics LLC, a US-based biotechnology firm, introduced target metabolite and lipid panels for biomarker discovery and rapid insights. These panels focus on identifying and quantifying specific metabolites and lipids, which enhances biomarker detection precision. Designed for quick results, these panels include advanced data analysis tools to interpret complex metabolic profiles and provide actionable insights, crucial for timely decision-making in both research and clinical environments.

In October 2022, Clinical-Microbiomics A/S, a Denmark-based company specializing in metabolome and microbiome analysis, acquired MS-Omics ApS for an undisclosed amount. This acquisition is aimed at strengthening Clinical-Microbiomics' capabilities in microbiome research and expanding its range of omics services by incorporating MS-Omics' expertise in mass spectrometry-based proteomics and metabolomics. MS-Omics ApS is a Denmark-based firm that provides metabolomics analysis services.

Major companies operating in the metabolomics services market are BASF SE, Waters Corporation, Bruker Corporation, RTI International, SCIEX, BGI Group, Fred Hutchinson Cancer Research Center, OWL Inc., LECO Corporation, Metabolon Inc., MetaSysX Inc., Nightingale Health, Biocrates Life Sciences AG, Human Metabolome Technologies America Inc., CosmosID, Centre for Cellular and Molecular Platforms, Creative Proteomics, Cogentech, Stemina Biomarker Discovery Inc., Thermal Management Innovations Corporation, Afekta Technologies Ltd., MS-Omics, Clinical Microbiomics, DNA Xperts Private Limited, Metware Biotechnology Co. Ltd

North America was the largest region in the metabolomics services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolomics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the metabolomics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metabolomics services market includes revenues earned by entities through metabolite identification, custom assay development, and metabolic profiling, and related nuclear magnetic resonance (NMR) spectroscopy systems, sample preparation kits, biomarker panels, and analytical platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metabolomics Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metabolomics services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metabolomics services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metabolomics services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Untargeted Metabolomics Services; Targeted Metabolomics Services
• 2) By Product And Service: Metabolomics Bioinformatics Services; Chromatography; Mass Spectrometry; Other Product And Services
• 3) By End-User: Agriculture And Food; Biomedical And Pharmaceutical; Academic And Research Labs; Diagnostic Laboratories; Other End-users
• Companies Mentioned: BASF SE; Waters Corporation; Bruker Corporation; RTI International; SCIEX
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metabolomics Services Market Characteristics

3. Metabolomics Services Market Trends And Strategies

4. Metabolomics Services Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Metabolomics Services Market Size and Growth

• 5.1. Global Metabolomics Services Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Metabolomics Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Metabolomics Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Metabolomics Services Market Segmentation

• 6.1. Global Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Untargeted Metabolomics Services
• Targeted Metabolomics Services
• 6.2. Global Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Metabolomics Bioinformatics Services
• Chromatography
• Mass Spectrometry
• Other Product And Services
• 6.3. Global Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Agriculture And Food
• Biomedical And Pharmaceutical
• Academic And Research Labs
• Diagnostic Laboratories
• Other End-Users

7. Metabolomics Services Market Regional And Country Analysis

• 7.1. Global Metabolomics Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Metabolomics Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Metabolomics Services Market

• 8.1. Asia-Pacific Metabolomics Services Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Metabolomics Services Market

• 9.1. China Metabolomics Services Market Overview
• 9.2. China Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Metabolomics Services Market

• 10.1. India Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Metabolomics Services Market

• 11.1. Japan Metabolomics Services Market Overview
• 11.2. Japan Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Metabolomics Services Market

• 12.1. Australia Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Metabolomics Services Market

• 13.1. Indonesia Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Metabolomics Services Market

• 14.1. South Korea Metabolomics Services Market Overview
• 14.2. South Korea Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Metabolomics Services Market

• 15.1. Western Europe Metabolomics Services Market Overview
• 15.2. Western Europe Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Metabolomics Services Market

• 16.1. UK Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Metabolomics Services Market

• 17.1. Germany Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Metabolomics Services Market

• 18.1. France Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Metabolomics Services Market

• 19.1. Italy Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Metabolomics Services Market

• 20.1. Spain Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Metabolomics Services Market

• 21.1. Eastern Europe Metabolomics Services Market Overview
• 21.2. Eastern Europe Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Metabolomics Services Market

• 22.1. Russia Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Metabolomics Services Market

• 23.1. North America Metabolomics Services Market Overview
• 23.2. North America Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Metabolomics Services Market

• 24.1. USA Metabolomics Services Market Overview
• 24.2. USA Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Metabolomics Services Market

• 25.1. Canada Metabolomics Services Market Overview
• 25.2. Canada Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Metabolomics Services Market

• 26.1. South America Metabolomics Services Market Overview
• 26.2. South America Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Metabolomics Services Market

• 27.1. Brazil Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Metabolomics Services Market

• 28.1. Middle East Metabolomics Services Market Overview
• 28.2. Middle East Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Metabolomics Services Market

• 29.1. Africa Metabolomics Services Market Overview
• 29.2. Africa Metabolomics Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Metabolomics Services Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Metabolomics Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Metabolomics Services Market Competitive Landscape And Company Profiles

• 30.1. Metabolomics Services Market Competitive Landscape
• 30.2. Metabolomics Services Market Company Profiles
  • 30.2.1. BASF SE
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Waters Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bruker Corporation
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. RTI International
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. SCIEX
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Metabolomics Services Market Other Major And Innovative Companies

• 31.1. BGI Group
• 31.2. Fred Hutchinson Cancer Research Center
• 31.3. OWL Inc.
• 31.4. LECO Corporation
• 31.5. Metabolon Inc.
• 31.6. MetaSysX Inc.
• 31.7. Nightingale Health
• 31.8. Biocrates Life Sciences AG
• 31.9. Human Metabolome Technologies America Inc.
• 31.10. CosmosID
• 31.11. Centre for Cellular and Molecular Platforms
• 31.12. Creative Proteomics
• 31.13. Cogentech
• 31.14. Stemina Biomarker Discovery Inc.
• 31.15. Thermal Management Innovations Corporation

32. Global Metabolomics Services Market Competitive Benchmarking

33. Global Metabolomics Services Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Metabolomics Services Market

35. Metabolomics Services Market Future Outlook and Potential Analysis

• 35.1 Metabolomics Services Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Metabolomics Services Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Metabolomics Services Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer